Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/1996
12/27/1996EP0749313A1 Method for treating 5ht 2b receptor related conditions
12/27/1996EP0572635B1 Compounds having a guanidine structure and pharmaceutical compositions containing same
12/27/1996CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists
12/25/1996CN1138859A Herbicidal aryl and heteroaryl pyrimidines
12/25/1996CN1138575A 4-aminobenzoylguanidine derivatives
12/25/1996CN1033642C Process for prepn. of substituted N-(aryl)-1,2,4-triazolopyrimdine-2-sulfonamides
12/25/1996CN1033640C 2-substituted-5-substituted-1, 3-oxathiolanes with antiviral properties
12/24/1996US5587400 Using an organoaluminum complex
12/24/1996US5587387 Heterocycle-substituted benzenemethanamine derivatives
12/24/1996US5587380 Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compounds
12/24/1996US5587379 Controlling insects in agricultural crops
12/24/1996US5587106 Liquid crystal display devices and liquid crystal substances therefor
12/19/1996WO1996041166A2 Detection of transmembrane potentials by optical methods
12/19/1996WO1996040709A1 Pna-dna chimeras and pna synthons for their preparation
12/19/1996WO1996040685A1 Improved synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
12/19/1996WO1996040680A1 Novel non-classical folate analogue inhibitors of glycinamide ribonucleotide formyltransferase (garft)
12/19/1996WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits
12/19/1996WO1996040663A1 Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins
12/19/1996WO1996040660A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996WO1996040648A1 Quinazolines and pharmaceutical compositions
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040622A1 Bis-(2-aryl)hydrazones as inhibitors of the formation of advanced glycosylation endproducts
12/19/1996WO1996040257A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996WO1996040201A1 Combinatorial libraries of substrate-bound cyclic organic compounds
12/19/1996WO1996040165A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
12/19/1996WO1996040142A1 Heterocyclic ring-fused pyrimidine derivatives
12/19/1996DE19521668A1 Substituierte Hydrazinophenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren Substituted Hydrazinophenylsulfonylharnstoffe, processes for their preparation and their use as herbicides and plant growth regulators
12/19/1996DE19521355A1 Sulfonamide, Verfahren zu deren Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren Sulfonamides, processes for their preparation and their use as herbicides and plant growth regulators
12/19/1996CA2224079A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996CA2223640A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2222545A1 Quinazolines and pharmaceutical compositions
12/19/1996CA2221508A1 Combinatorial libraries of substrate-bound cyclic organic compounds
12/19/1996CA2220958A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/18/1996EP0748800A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists
12/18/1996EP0748465A1 Dihydroperimidine squarylium dyes as antihalation and acutance materials for photographic and photothermographic articles
12/18/1996EP0748316A1 Pyrimidine acyclonucleoside derivatives
12/18/1996EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
12/18/1996EP0526598B1 New pharmacologically active catechol derivatives
12/17/1996US5585513 Fungicides
12/17/1996US5585397 Viricides
12/17/1996US5585381 Pyrimidine derivatives and pharmaceutical composition
12/17/1996US5585036 Liquid crystal compounds containing chiral 2-halo-2-methyl ether and ester tails
12/12/1996WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996WO1996039145A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
12/12/1996WO1996030344A3 Pyrimidine compounds
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/11/1996EP0747365A1 Process and intermediates for the manufacture of herbicidal 1- [2-(cyclopropylcarbonyl)phenyl] sulfamoyl -3-(4,6-dialkoxy-2-pyrimidinyl)urea compounds
12/11/1996EP0747364A2 Process for the preparation of 2,4,6-trichloropyrimidine
12/11/1996EP0747352A1 Cyclic nitrogenous compound and herbicide
12/11/1996EP0746557A1 Intracellular signalling mediators
12/11/1996EP0746554A1 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
12/11/1996EP0746326A1 Oligomeric compounds having nitrogen-containing linkages
12/11/1996EP0640092B1 A process for the preparation of ribonucleotide reductase inhibitors
12/11/1996CN1137548A Cyanation of double bond systems
12/10/1996US5583238 Method for making intermediates useful in synthesis of retroviral protease inhibitors
12/10/1996US5583233 Retroviral protease inhibiting compounds
12/10/1996US5583232 Treating human immunodeficiency virus infections
12/10/1996US5583226 Chemical intermediates of viricidal nucleotides
12/10/1996US5583145 Psychological disorders
12/10/1996CA2178548A1 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydro-quinazolinedione derivatives as .alpha.1 adrenergic receptor antagonists
12/05/1996WO1996038446A1 Fused polycyclic heterocycle derivatives
12/05/1996WO1996038439A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them
12/05/1996WO1996038421A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants
12/05/1996WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996CA2221992A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants
12/05/1996CA2196425A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them
12/04/1996EP0745593A2 Process of preparation of pure 4,6-dichloropyrimidine
12/04/1996EP0745592A1 Antiferroelectric liquid crystal compound and antiferroelectric liquid crystal composition containing the same
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1137037A Quinazoline derivatives
12/04/1996CN1033452C 1-Û|0-(cyclopropyl carbonyl) phenyl¨ sulfamoylÙ-3-(4,6 dimethoxy-2-pyrimidinyl) urea and method for preparation thereof
12/04/1996CN1033451C Alpha-substituted benzenemethanamine derivatives
12/03/1996US5580984 Retroviral protease inhibiting compounds
12/03/1996US5580972 Displacement of halogen leaving group attached to purine ring with organotin compound in presence of palladium catalyst
12/03/1996US5580904 Penetrate blood-brain barrier
12/03/1996US5580891 Antipsychotic agents, analgesics
12/03/1996US5580890 Psychological disorders
12/03/1996US5580889 Insecticidal nitromethyl or niteoimino-heteromethyl-heterocyclics
12/03/1996US5580888 Administering for therapy and prophylaxis of asthma; potent phosphodiesterase iv isoenzyme inhibitors
12/03/1996US5580887 1- (arylthioalkyl , arylaminoalkyl or arylmethylenealkyl) -4- (heteroaryl) piperidines and related compounds useful as anti-psychotics and analgesics
12/03/1996US5580886 Cis-2-[(4-heteroaryl-1-piperidinyl)alkyl]hexahydro-1H-isoindole-1,3(2H)-diones and related compounds and their therapeutic utility
12/03/1996US5580879 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]-1H-benz[DE]isoquinoline-1;3(2H)-diones and related compounds and their therapeutic utility
12/03/1996US5580875 Antipsychotic and analgesic agents
12/03/1996US5580870 Quinazoline derivatives
12/03/1996CA2115461C Enzymatic analysis using substrates that yield fluorescent precipitates
12/03/1996CA2002671C Process for the production of 4,5-dichloro-6-ethyl-pyrimidine
11/1996
11/28/1996WO1996037451A1 Liquid crystalline compounds having exo-methylene site and liquid crystal compositions comprising the same
11/26/1996US5578624 Heteroarylpyrrolidines and their use as antipsychotics and analgesics
11/26/1996US5578606 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
11/26/1996US5578605 N-[(4-heteroaryl)-1-piperidinyl)alkyl]-1,2,3,4-tetrahydroquinolines and related compounds and their therapeutic utility
11/26/1996US5578595 Cyclopropylacetic acid derivatives
11/26/1996US5578242 Liquid crystals
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/21/1996WO1996036614A1 Aminouracil derivates
11/21/1996WO1996036613A1 Substituted benzoic acid derivatives, process for the production thereof, and herbicides
11/21/1996DE19517732A1 Aminouracilderivate Aminouracilderivate
11/20/1996EP0743308A2 Quinazoline compound and anti-tumor agent containing said compound as an active ingredient
11/20/1996EP0743307A1 Sulfonamide derivative and process for preparing the same
1 ... 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 ... 427